This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Hyundai Pharm Co., Ltd., Hyundai Pharm Co., Ltd.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Jeong Un Hwang: Innovator in Pharmaceutical Chemistry
Introduction
Jeong Un Hwang is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on the development and evaluation of pharmaceutical compounds, showcasing his expertise in this specialized area.
Latest Patents
Hwang's latest patents include a method for evaluating the quality of (3S)-3-(4-(3-(1,4-dioxaspiro[4,5]dec-7-en-8-yl)benzyloxy)phenyl)hex-4-inoic acid. This invention provides a related substance and a method for assessing the quality and stability of pharmaceutical compositions containing this compound. Another significant patent is for a novel crystal form of a 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative. This crystal form exhibits superior physicochemical properties, making it particularly useful for preparation and long-term storage.
Career Highlights
Throughout his career, Jeong Un Hwang has worked with Hyundai Pharm Co., Ltd., where he has contributed to various innovative projects. His work has been instrumental in advancing pharmaceutical formulations and improving the quality of medicinal products.
Collaborations
Hwang has collaborated with notable colleagues such as Jin Woong Kim and Kyu Hwan Lee. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical technologies.
Conclusion
Jeong Un Hwang's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to impact the industry positively, paving the way for advancements in drug development and evaluation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
